Search
Menu
Rocky Mountain Instruments - Custom Assemblies LB

SurgiLight Begins Phase I Clinical Studies in Spain

Facebook X LinkedIn Email
ORLANDO, Fla., March 9 -- SurgiLight Inc. announced that it would begin Human Phase I clinical studies using its IR-3000 laser for Laser Presbyopia Reversal (LPR) in Spain within a month. Presbyopia is a visual condition in which loss of elasticity of the lens of the eye causes defective accommodation and inability to focus sharply for near vision.    The company has received Institutional Review Board (IRB) approval at the Department of Ophthalmology, Institute Universitari Dexus, where Carlos Verges will perform this Phase I clinical study on a total of ten eyes. This clinical study follows...Read full article

Related content from Photonics Media

    Published: March 2001
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.